Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the clinical trial study content.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedLocation entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.1%

- Check44 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision tag updated: v3.4.2 added and previous tag v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.